What Tests Need To Be Done To Start GLP-1 Treatment
Rather, it reveals predispositions in peptide genetic pathways, such as GIPR rs1800437, which may correlate with variability in GLP-1 medication effectiveness and metabolic flexibility
I feel more energized throughout the day, and Im not as sluggish or tired as I used to be
Head-to-Head Comparison The most direct comparison came from the SURMOUNT-5 trial, which evaluated tirzepatide compared to semaglutide in adults with obesity
However, published data allows a directional comparison of the most common GI events: Adverse Event Retatrutide (12 mg) Semaglutide 2.4 mg (STEP trials) Tirzepatide 15 mg (SURMOUNT trials) Nausea ~46% ~44% ~31% Diarrhea ~33% ~30% ~23% Vomiting ~22% ~24% ~12% Constipation ~17% ~24% ~12% Important caveat: These numbers come from different trial populations and cannot be directly compared
Choose a moderate-concentration product from a reputable brand